Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia

Clinical Infectious Diseases

Volumn 54, Issue 8, 2012, Pages 1126-1133

  Moran, Gregory J ^a,b   Krishnadasan, Anusha ^a   Gorwitz, Rachel J ^c   Fosheim, Greg E ^c   Albrecht, Valerie ^c   Limbago, Brandi ^c   Talan, David A ^a,b  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; HYPERTENSIVE FACTOR; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; COMATOSE PATIENT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; LUNG CAVITY; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; NURSING HOME; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SKIN INFECTION; THORAX RADIOGRAPHY;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, STAPHYLOCOCCAL;

EID: 84859066905     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis022     Document Type: Article

References (24)

1. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990; 69: 307-16.
2. Rello J, Bodi M, Mariscal D, et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003; 123:174-80.
3. Beović B, Bonac B, Kese D, et al. Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 2003; 22:584-91.
4. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of communityacquired pneumonia requiring hospitalization. Results of a populationbased active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709-18.
5. Marrie TJ, Poulin-Costello M, Beecroft MD, Herman-Gnjidic Z. Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir Med 2005; 99:60-5.
6. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
7. Francis JS, Doherty MC, Lopatin U, et al. Severe communityonset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentin leukocidin genes. Clin Infect Dis 2005; 40:100-7.
8. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894-9.
9. Centers for Disease Control and Prevention. Severe methicillinresistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56: 325-9.
10. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315-21.
11. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805-11.
12. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009; 53:358-65.
13. Kallen AJ, Reed C, Patton M, et al. Staphylococcus aureus communityonset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006-2007. Epidemiol Infect 2010; 138:666-72.
14. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl 2):S27-72.
15. Talan DA, Moran GJ, Mower W, et al. EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. Ann Emerg Med 1998; 32:703-11.
16. Murray PR, Baron EJ, Jorgensen J, et al. Manual of clinical microbiology. 8th Ed. Washington, DC: ASM Press, 2003.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Wayne, PA: Clinical and Laboratory Standards Committee, 2006:M100-S16.
18. Limbago B, Fosheim GE, Schoonover V, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009; 47:1344-51.
19. McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113-20.
20. Chickering HT, Park JH. Staphylococcus aureus pneumonia. N Engl J Med 1919; 72:617-26.
21. Goslings WR, Mulder J, Djajadiningrat J. Staphylococcal pneumonia in influenza: in relation to antecedent staphylococcal skin infection. Lancet 1959; 2:428-30.
22. Lobo LJ, Reed KD, Wunderink RG. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 2010; 138:130-6.
23. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32.
24. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in adults and children. Clin Infect Dis 2011; 52:285-92.